Recurring Features
The fixtures you can count on — every Monday, every month, every quarter. The cadence that keeps you ahead, on a schedule you can plan around.
The Monday Brief — Week of Jun 26, 2026
New FDA approvals reshape the injectables menu. AbbVie signals margin pressure. InMode faces a buyout bid. And the compliance crackdown continues.
MonthlyMonthly Regulatory Roundup — June 2026
Seven new device clearances, a critical injectable recall, and major FDA scrutiny of dermal fillers—here's what you need to do now.
QuarterlyQuarterly Device Clearance Digest — Q2 2026
Nine new FDA 510(k) clearances and a major corporate restructuring at Bausch Health signal a busy quarter for aesthetic device buyers.
QuarterlyQuarterly Pricing Pulse — Q2 2026
Loyalty programs tighten, price wars intensify, and GLP-1 reshapes the medspa margin game. Here's what moved—and what to do.
AnnualYear in Aesthetics — 2026
Pricing wars, new injectables, FDA approvals, and M&A reshape the medical aesthetics landscape—and your bottom line.